Clinical Trial Update: Effect of Bevacizumab on Asymptomatic Radiotherapy-induced Brain Injury [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the effect of bevacizumab on radiotherapy-induced brain injury in asymptomatic patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Injury
• Radiotherapy-induced Brain Injury

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Brain Injuries | Phase 2 | Status: UNKNOWN